JP2000515025A - ヒト成長遺伝子及び低身長遺伝子領域 - Google Patents

ヒト成長遺伝子及び低身長遺伝子領域

Info

Publication number
JP2000515025A
JP2000515025A JP10516222A JP51622298A JP2000515025A JP 2000515025 A JP2000515025 A JP 2000515025A JP 10516222 A JP10516222 A JP 10516222A JP 51622298 A JP51622298 A JP 51622298A JP 2000515025 A JP2000515025 A JP 2000515025A
Authority
JP
Japan
Prior art keywords
seq
dna
sequence
shox
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10516222A
Other languages
English (en)
Japanese (ja)
Inventor
ラッポルト―ヘールブラント，グドゥルン
ラオ，エルコレ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2000515025A publication Critical patent/JP2000515025A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
JP10516222A 1996-10-01 1997-09-29 ヒト成長遺伝子及び低身長遺伝子領域 Pending JP2000515025A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2763396P 1996-10-01 1996-10-01
EP97100583.0 1997-01-16
EP027,633 1997-01-16
EP97100583 1997-01-16
PCT/EP1997/005355 WO1998014568A1 (en) 1996-10-01 1997-09-29 Human growth gene and short stature gene region

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004058276A Division JP2004201692A (ja) 1996-10-01 2004-03-02 ヒト成長遺伝子及び低身長遺伝子領域

Publications (1)

Publication Number Publication Date
JP2000515025A true JP2000515025A (ja) 2000-11-14

Family

ID=26145174

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10516222A Pending JP2000515025A (ja) 1996-10-01 1997-09-29 ヒト成長遺伝子及び低身長遺伝子領域
JP2004058276A Pending JP2004201692A (ja) 1996-10-01 2004-03-02 ヒト成長遺伝子及び低身長遺伝子領域

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004058276A Pending JP2004201692A (ja) 1996-10-01 2004-03-02 ヒト成長遺伝子及び低身長遺伝子領域

Country Status (20)

Country Link
US (2) US7252974B2 (enExample)
EP (2) EP0946721B1 (enExample)
JP (2) JP2000515025A (enExample)
KR (1) KR20000048838A (enExample)
CN (1) CN1232499A (enExample)
AT (1) ATE230026T1 (enExample)
AU (1) AU744188C (enExample)
BR (1) BR9712185A (enExample)
CA (2) CA2267097A1 (enExample)
CZ (1) CZ297640B6 (enExample)
DE (1) DE69718052T2 (enExample)
DK (1) DK0946721T3 (enExample)
ES (1) ES2188992T3 (enExample)
HU (1) HU225131B1 (enExample)
IL (1) IL129015A0 (enExample)
NO (1) NO991554L (enExample)
NZ (1) NZ334970A (enExample)
PL (1) PL194248B1 (enExample)
SI (1) SI0946721T1 (enExample)
WO (1) WO1998014568A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056765A1 (en) * 1999-03-19 2000-09-28 Human Genome Sciences, Inc. 48 human secreted proteins
AU3913100A (en) * 1999-03-26 2000-10-16 Human Genome Sciences, Inc. 50 human secreted proteins
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
WO2003038087A1 (en) 2001-10-04 2003-05-08 Kansai Technology Licensing Organization Co., Ltd. DR5 GENE PROMOTER AND Siah-1 GENE PROMOTER
EP1583554A2 (en) * 2003-01-13 2005-10-12 Gudrun Rappold-Hoerbrand Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
ES2533767T3 (es) 2005-04-15 2015-04-15 Epigenomics Ag Métodos para el análisis de trastornos proliferativos celulares
US7382944B1 (en) 2006-07-14 2008-06-03 The United States Of America As Represented By The Administration Of The National Aeronautics And Space Administration Protective coating and hyperthermal atomic oxygen texturing of optical fibers used for blood glucose monitoring
ES2384071T3 (es) * 2007-01-19 2012-06-29 Epigenomics Ag Métodos y ácidos nucleicos para análisis de trastornos proliferativos celulares
WO2014182595A1 (en) * 2013-05-06 2014-11-13 Mikko Sofia Diagnostic test for skeletal atavism in horses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445933A1 (de) * 1984-12-17 1986-06-19 Röhm GmbH, 6100 Darmstadt Arzneimittel mit diuretischer wirksamkeit
US4983511A (en) * 1989-01-09 1991-01-08 Olin Corporation Method and kit for detecting live microorganisms in chlorine- or bromine-treated water

Also Published As

Publication number Publication date
IL129015A0 (en) 2000-02-17
EP0946721A1 (en) 1999-10-06
PL194248B1 (pl) 2007-05-31
HU225131B1 (en) 2006-06-28
BR9712185A (pt) 1999-08-31
CA2267097A1 (en) 1998-04-09
DE69718052T2 (de) 2003-07-31
NO991554L (no) 1999-05-14
ES2188992T3 (es) 2003-07-01
JP2004201692A (ja) 2004-07-22
PL332568A1 (en) 1999-09-27
US20090111744A1 (en) 2009-04-30
WO1998014568A1 (en) 1998-04-09
HUP9904175A3 (en) 2002-01-28
DK0946721T3 (da) 2003-04-14
NZ334970A (en) 2000-12-22
EP1260228A3 (en) 2003-03-05
NO991554D0 (no) 1999-03-30
AU744188B2 (en) 2002-02-14
US20030059805A1 (en) 2003-03-27
AU4625297A (en) 1998-04-24
CZ297640B6 (cs) 2007-02-21
CN1232499A (zh) 1999-10-20
KR20000048838A (ko) 2000-07-25
CZ96699A3 (cs) 1999-08-11
HUP9904175A2 (hu) 2000-04-28
EP0946721B1 (en) 2002-12-18
EP1260228A2 (en) 2002-11-27
AU744188C (en) 2003-07-24
CA2647169A1 (en) 1998-04-09
ATE230026T1 (de) 2003-01-15
DE69718052D1 (de) 2003-01-30
US7252974B2 (en) 2007-08-07
SI0946721T1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
Rao et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome
JP4463329B2 (ja) Ｃａｄａｓｉｌに関与する遺伝子、診断方法および治療への適用
JP3096739B2 (ja) Ｈｌａ分子によって提示される単離ノナペプチドとその使用
CA2160937C (en) Survival motor neuron (smn) gene: a gene for spinal muscular atrophy
US20090111744A1 (en) Human Growth Gene and Short Stature Gene Region
US6602667B1 (en) Inflammation-associated polynucleotides
US6316597B1 (en) Sox-9 gene and protein and use in the regeneration of bone or cartilage
JP2001515349A (ja) Ｔｍ４ｓｆヒト腫瘍関連抗原
JPWO2000017345A1 (ja) Ｌｙ６ｈ遺伝子
JP2002511749A (ja) ９ｑ３２−３３での腫瘍サプレッサー遺伝子ＤＢＣＣＲ１
Lüdecke et al. Genes and chromosomal breakpoints in the Langer-Giedion syndrome region on human chromosome 8
PT613945E (pt) Gene merlin supressor de tumores e suas utilizacoes
US6555670B1 (en) Testis-specific gene
Burke et al. Zfp-37, a new murine zinc finger encoding gene, is expressed in a developmentally regulated pattern in the male germ line
US6586581B1 (en) Prolactin regulatory element binding protein and uses thereof
US20020009720A1 (en) Plag gene family and tumorigenesis
CA2413670C (en) Human brain and testis-specific immunoglobulin superfamily (bt-igsf) cdna for diagnosis of aplasia of corpus callosum and aspermatogenesis
WO2002101002A2 (en) Identification of snps the hgv-v gene
US6309821B1 (en) DNA encoding a PAC10 human homolog
US20020064855A1 (en) Genes that regulate hematopoietic blood forming stem cells and uses thereof
US20070128645A1 (en) Use of KIAA0172 gene in treatment and diagnosis of diseases as well as in pharmaceutical development
US20030027152A1 (en) Generation of diagnostic tools to assay the human LHX3/P-LIM/LIM-3 factor
US20030027166A1 (en) Coding sequence haplotype of the human BRCA1 gene
JPH10127296A (ja) Ｅｘｔ２遺伝子
JP2002534963A (ja) 創傷治癒および口腔顔面裂

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20031128

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040302

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050207

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20050324

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20051006

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070702

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070705